electroCore — Third Quarter 2026 Earnings Summary

electroCore reported third-quarter 2026 net sales of $9.7 million, representing a 12% increase over the prior year period. The company achieved a GAAP net loss of $1.3 million, a 61% improvement from the previous year, while Adjusted EBITDA loss narrowed by 67% to $0.7 million. Growth was primarily driven by a 25% increase in U.S. prescription revenue, with the Veterans Affairs channel serving as the key expansion driver. Additionally, the company revised its full-year 2026 revenue outlook to a range of $39 million to $42 million and introduced preliminary guidance for 2027.